Olivier Bonnot

ORCID: 0000-0003-0005-4765
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Attention Deficit Hyperactivity Disorder
  • Schizophrenia research and treatment
  • Pharmaceutical studies and practices
  • Psychoanalysis and Psychopathology Research
  • Bipolar Disorder and Treatment
  • Child Nutrition and Feeding Issues
  • Autism Spectrum Disorder Research
  • Electroconvulsive Therapy Studies
  • Child and Adolescent Psychosocial and Emotional Development
  • Maternal Mental Health During Pregnancy and Postpartum
  • Lysosomal Storage Disorders Research
  • Metabolism and Genetic Disorders
  • Pharmacological Effects and Toxicity Studies
  • Psychosomatic Disorders and Their Treatments
  • Neuroscience and Music Perception
  • Child Development and Digital Technology
  • Genetic Syndromes and Imprinting
  • Alcoholism and Thiamine Deficiency
  • Family and Disability Support Research
  • Genetics and Neurodevelopmental Disorders
  • Mental Health Research Topics
  • Digital Mental Health Interventions
  • Folate and B Vitamins Research
  • Cardiac electrophysiology and arrhythmias
  • Music Therapy and Health

Centre de recherche en Epidémiologie et Santé des Populations
2025

Inserm
2025

Laboratoire de Psychologie des Pays de la Loire
2015-2024

Nantes Université
2014-2024

Fondation FondaMental
2023

Centre Hospitalier Universitaire de Nantes
2013-2022

Université d'Angers
2016-2022

Université de Lorraine
2020

Interpsy
2020

Centre d'Investigation Clinique de Nantes
2019

The term "digital phenotype" refers to the digital footprint left by patient-environment interactions. It has potential for both research and clinical applications but challenges our conception of health care opposing 2 distinct approaches medicine: one centered on illness with aim classifying curing disease, other patients, their personal distress, lived experiences. In context mental psychiatry, benefits phenotyping include creating new avenues treatment enabling patients take control own...

10.2196/44502 article EN cc-by Journal of Medical Internet Research 2023-08-21

Abstract Prader–Willi Syndrome (PWS) is a rare genetic syndrome leading to severe behavioural disorders and mild cognitive impairment. The objective of this double-blind randomised placebo-controlled trial was study the efficacy tolerance topiramate on in patients with PWS. Participants (aged 12–45 years) had genetically confirmed PWS irritability/impulsivity, eating and/or obesity, skin picking. Thirty-two participants received placebo (PBO), 30 (TOP) (50–200 mg/day) for 8 weeks. primary...

10.1038/s41398-019-0597-0 article EN cc-by Translational Psychiatry 2019-11-04

Abstract Anti-NMDA-Receptor encephalitis is a severe form of that was recently identified in the context acute neuropsychiatric presentation. Here, we describe case 17-year-old girl referred for an mania with psychotic features and clinical picture deteriorated to catatonic state. Positive diagnosis anti-NMDA-receptor suggested specific treatment. She improved after plasma exchange immunosuppressive therapy. Post-cognitive sequelae (memory impairment) disappeared within 2-year follow-up...

10.1186/1753-2000-5-15 article EN cc-by Child and Adolescent Psychiatry and Mental Health 2011-05-13

Clinical observations suggest early self-consciousness disturbances in schizophrenia. A double mirror combining the images of two individuals sitting on each side was used to study self-other differentiation 12 with onset schizophrenia (EOS) and 15 adult (AOS) compared 27 typically developing controls (TDC) matched age sex. The effects intermodal sensory perception (visual-tactile visual-kinesthetic) recognition were also studied. results showed that EOS AOS individuals, independently...

10.1038/s41537-018-0065-5 article EN cc-by Schizophrenia 2018-11-21
Coming Soon ...